Advertisement
The U.S. Centers for Disease Control and Prevention has released new recommendations on how long men with either Zika infection or exposure should abstain from trying to conceive. The recommendations have been published in the Sept. 30 early-release issue of the CDC's Morbidity and Mortality Weekly Report.

Men With Zika Exposure to Abstain From Conceiving Longer

0
Waiting period lengthened from eight weeks to six months
In correspondence published in the October issue of The Lancet Infectious Diseases

Zika Virus Found in Sperm, Not Just Semen

0
Findings in traveler from French Guyana; similar results seen in two other patients
A doctor's political beliefs can sway their treatment decisions

Political Views May Influence Doctors’ Advice, Decisions

0
Voting issues may affect guidance on abortion, guns, marijuana
Older adults have high incidence of cardiovascular risk factors

High Incidence of Cardiovascular Risk Factors in Older Adults

0
Blacks have increased incidence of hypertension, diabetes mellitus, dyslipidemia, but not a-fib
Statin therapy is associated with reduced risk of all-cause and multiple myeloma-specific mortality

Statins Reduce Risk of Mortality in Multiple Myeloma

0
Reduced risk of both all-cause and multiple myeloma-specific mortality in cohort of veterans
Adhering to medication regimens for the treatment of psoriasis can be an additional source of considerable emotional distress for patients

Medication Adherence Stressful for Psoriasis Patients

0
When clinicians do not address patients' difficulties, it can increase their emotional distress
Young adults with long-standing

Increased Total, CVD Mortality in Young Adults With T1DM

0
Incident rate ratio for hospitalized CVD about 8; revascularization accounts for much of increased risk
For patients with nonalcoholic fatty liver disease and underlying metabolic disorders

Physical Activity Reduces Intrahepatic Lipid Content

0
Reductions also seen in alanine aminotransferase and aspartate aminotransferase in NAFLD
Dupilumab is effective for patients with moderate-to-severe atopic dermatitis that is inadequately controlled by topical treatment

Dupilumab Effective in Atopic Dermatitis

0
Primary outcome occurred significantly more often for patients receiving dupilumab in SOLO 1, SOLO 2
A novel proactive multidisciplinary service model can identify falls

Novel Proactive Model Identifies Falls, Syncope, Dizziness

0
Significant numbers of individuals ID'd with new diagnoses such as cognitive impairment, Parkinson's